Following the precise identification of tumour cell dependence for IL-6 (expression of IL-6 and its receptor IL-6R) in a panel of ten cell lines (of myeloma, leukemia or lymphoma origins), we determined their individual response to different doses of radiations and chemotherapeutic drugs. This evidence concerns the gene IL6 and leukemia.